SARM1 (Sterile Alpha and TIR Motif Containing 1) plays an important role in neurodegenerative diseases. This page provides comprehensive information about its mechanisms, significance in disease processes, and therapeutic implications.
SARM1 is an important component in the neurobiology of Alzheimer's disease, Parkinson's disease, ALS, and other neurodegenerative conditions. This page provides detailed information about its structure, function, and role in disease processes.
SARM1 is the central executioner of programmed axon degeneration. Its intrinsic NADase activity triggers rapid axonal breakdown following injury, making it a critical therapeutic target for Wallerian degeneration, ALS, PD, and AD.
In neurodegenerative diseases, SARM1 activation contributes to:
| Property | Value | [1]
|----------|-------| [2]
| Protein Name | SARM1 |
| Gene | SARM1 |
| UniProt ID | Q6S5P3 |
| PDB Structures | 6O0W, 6VYZ |
| Molecular Weight | 89.5 kDa |
| Subcellular Localization | Axonal, mitochondrial associated |
| Protein Family | TIR domain-containing protein family |
| Compound | Mechanism | Stage |
|---|---|---|
| 1E7-03 | TIR domain NADase inhibitor | Preclinical |
| 4B7 | NADase inhibition | Research |
| Gene therapy | shRNA/siRNA targeting SARM1 | Preclinical |
Sarm1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Sarm1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.